Compare Align Technology, Inc. (ALGN) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Nomura Holdings Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Nomura Holdings Inc trades at $9.66 (market cap $27.88B). The key difference: Nomura Holdings Inc is far larger — about 2.2× Align Technology, Inc.'s market cap, and Nomura Holdings Inc pays a 3.35% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | NMR | |
|---|---|---|
Market Cap | $12.86B | $27.88B |
Sector | Health | Financials |
52-Week High | $207.19 | $9.66 |
52-Week Low | $124.88 | $6.30 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 3.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Nomura Holdings (NMR) trades at $9.66, up 1.26% today, with a bullish technical signal from moving averages. The company reported record annual revenue of $1.66 trillion and net income of $340.74 billion for 2025, driving a net income margin of 20.49%. Recent news highlights strong wholesale revenue growth and strategic acquisitions, while analyst consensus shows a hold-heavy rating with 33% buy recommendations.
The outlook is mixed; robust profitability and expansion in core segments support upside, but consecutive earnings misses and rising debt-to-asset ratios pose risks. Investor sentiment is cautiously optimistic, with technical indicators suggesting near-term momentum but overbought conditions on shorter-term RSI readings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
